HCMC – FV Hospital has announced an investment of nearly VND200 billion in the CyberKnife S7 radiosurgery system, becoming the first hospital in Vietnam and Southeast Asia to adopt the latest generation of non-invasive robotic radiosurgery technology.
As the latest version, the CyberKnife S7 radiosurgery system is revolutionizing cancer treatment with its minimally invasive radiosurgery technology. Notably, it can also target tumors that move, enhancing safety, shortening treatment time, and significantly reducing side effects.
“The CyberKnife S7 is the world’s only radiosurgery robot capable of real-time, personalized cancer treatment,” said Nguyen Thanh Duy, CEO of TD Tech and representative of U.S.-based Accuray Incorporated, at a technology transfer and purchase signing ceremony on May 6.
“Using artificial intelligence, it continuously tracks tumors during treatment and adjusts the radiation beams accordingly as the patient breathes or the tumor shifts. This not only enhances treatment precision but also shortens the duration. The treatment can now be completed in just one to five sessions, compared to the 10 to 40 sessions typically required with conventional therapies. In addition to cancer, this latest-generation system can also be used for non-invasive treatment of various other conditions, such as brain vascular malformations and cardiac arrhythmias,” Duy added.
Notably, cancer treatment using the CyberKnife S7 is covered by social healthcare insurance.
Jean-Marcel Guillon, CEO of FV Hospital, said the decision to invest in CyberKnife S7 aims to enhance the hospital’s capabilities in non-invasive cancer treatment. He noted that the technology is already in use at leading hospitals worldwide. With this investment, the Hy Vong Cancer Care Centre at FV Hospital is set to reach a new level, establishing itself as a pioneering cancer treatment center in the region.
The system operates in a specially designed basement space meeting strict safety standards. Its deployment at FV Hospital is supported by a trained team of doctors, technicians, and continuous collaboration with the manufacturer.
Dr. Basma M’Barek, head of the hospital’s Hy Vong Cancer Care Centre, highlighted that the technology can also be used to treat benign conditions, a feature not available in many other radiation systems.
In addition, CyberKnife S7 integrates AI-powered Synchrony technology, enabling it to deliver radiation with sub-millimeter accuracy through a robotic arm equipped with a 6MV linear accelerator. It allows real-time imaging guidance and individualized treatment by tracking tumor motion continuously during therapy.
The Hy Vong Cancer Care Centre – FV Hospital has positioned itself as one of the region’s leading cancer treatment hubs, offering a full range of oncology services, including diagnostics, surgery, chemotherapy, radiotherapy, pain management, psychological support, and palliative care.
